CXCL12 and breast carcinoma: There were significant differences between high- and low-risk groups in terms of prognosis, clinical characteristics, enrichment pathways, TMB, immune infiltration and treatment responses, which could help us to better understand the immunological implication and prognostic significance of CXCL12 in breast cancer, and establish novel directions for further exploration and research.